Up to the Challenge: Improving T2D Outcomes with GLP-1 RAs
AACE has partnered with several state associations to educate family physicians, physicians' assistants, and nurses in new ways to help diabetes patients. These one-hour talks are designed to equip primary care clinicians with evidence-based knowledge and increased competence about glucagon-like peptide 1 receptor agonists (GLP 1 RAs). Using an interactive format, participants will learn an overview of GLP 1 RA therapies, including MOA and treatment options, as well as participate in case-based discussion to learn how to integrate these therapies into clinical care. Available for 1.0 AMA PRA Category 1 Credit™.
This activity is supported by independent educational grants from Lilly USA, LLC and Novo Nordisk Inc.
These sessions will be offered in conjunction with meetings around the country, currently scheduled as follows:
|May 21, 2021
||Vermont Nurse Practitioners Association